Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.40 |
| ▸ | PSEN1 | P49768 | 15/20 | 0.39 |
| ▸ | PSEN2 | P49810 | 13/20 | 0.39 |
| ▸ | APH1B | Q8WW43 | 12/20 | 0.39 |
| ▸ | NCSTN | Q92542 | 12/20 | 0.39 |
| ▸ | APH1A | Q96BI3 | 12/20 | 0.39 |
| ▸ | PSENEN | Q9NZ42 | 12/20 | 0.39 |
| ▸ | APP | P05067 | 11/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14441562 | 1.00 | CYP3A4 (0.40) | CYP3A4PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL12147365 | 1.00 | CYP3A4 (0.40) | CYP3A4PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL12147329 | 1.00 | CYP3A4 (0.40) | CYP3A4PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL8240894 | 0.88 | PSEN1 (0.38) | CYP3A4PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL1363503 | 0.87 | PSEN1 (0.38) | CYP3A4PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL1363504 | 0.87 | PSEN1 (0.38) | CYP3A4PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL1364934 | 0.87 | PSEN1 (0.38) | CYP3A4PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL1364936 | 0.87 | PSEN1 (0.38) | CYP3A4PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL1363505 | 0.87 | PSEN1 (0.38) | CYP3A4PSEN1PSEN2APH1BNCSTN | |
| SCHEMBL12148181 | 0.86 | MMP13 (0.40) | PSEN1PSEN2APH1BNCSTNAPH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8569521-B2 | Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors | MERCK SHARP & DOHME CORP. (US) | 2013-10-29 | — | — | US | disclosed |
| EP-1976843-B1 | CARBOCYCLIC AND HETEROCYCLIC ARYLSULFONES AS GAMMA SECRETASE INHIBITORS | MERCK SHARP & DOHME (US) | 2013-09-04 | — | — | EP | disclosed |
| US-20120264736-A1 | BENZENESULFONYL-CHROMANE, THIOCHROMANE, TETRAHYDRONAPHTHALENE AND RELATED GAMMA SECRETASE INHIBITORS | SCHERING CORPORATION (US) | 2012-10-18 | — | — | US | disclosed |
| US-8067621-B2 | Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors | SCHERING CORPORATION (US) | 2011-11-29 | — | — | US | disclosed |
| EP-1976843-A2 | CARBOCYCLIC AND HETEROCYCLIC ARYLSULFONES AS GAMMA SECRETASE INHIBITORS | SCHERING CORPORATION (US) | 2008-10-08 | — | — | EP | disclosed |
| US-20070197581-A1 | Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors | MERCK SHARP & DOHME LLC | 2007-08-23 | — | — | US | disclosed |
| WO-2007084595-A2 | CARBOCYCLIC AND HETEROCYCLIC ARYLSULFONES AS GAMMA SECRETASE INHIBITORS | SCHERING CORPORATION (US) | 2007-07-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120264736-A1 | BENZENESULFONYL-CHROMANE, THIOCHROMANE, TETRAHYDRONAPHTHALENE AND RELATED GAMMA SECRETASE INHIBITORS | BACE1, PSEN1, BACE2 | CYP3A4 567/4885PSEN1 2/4885PSEN2 4/4885 |
| US-20070197581-A1 | Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors | BACE1, BACE2, PSEN1 | CYP3A4 593/4885PSEN1 3/4885PSEN2 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.